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INTRODUCTION
Defining mechanisms that contribute to establishing and
maintaining cellular differentiation is crucial for advancing our
understanding of cellular development and a novel approach for
targeting cancer therapies. A key feature of differentiation involves
activation of transcription networks controlling global gene
expression to ensure cell commitment to a specific phenotype. In the
mammary gland, differentiation of the mammary epithelium takes
place throughout the reproductive lifetime of the female. During
puberty, terminal end bud (TEB) structures form and are responsible
for ductal elongation. As the ducts mature, the cells differentiate into
luminal or myoepithelial cells. During pregnancy, alveolar structures
form and the luminal epithelium begins to acquire the ability to
produce milk. When the offspring are weaned, the majority of
alveolar epithelial cells die and the gland regresses, but it maintains
the ability to expand in response to subsequent pregnancies. The
mammary alveolar epithelial cells respond to the hormone prolactin
by initiating a cascade of events leading to activation and nuclear
translocation of Stat5a, which binds to regulatory elements of milk
protein genes, increasing their expression (Happ and Groner, 1993;
Li and Rosen, 1995). Although prolactin-mediated Stat5a activation
is central to alveolar epithelial cell function, it is not the only
pathway responsible for initiating mammary gland specification
towards terminal differentiation. Other transcription factors,
including glucocorticoid receptor (GR; Nr3c1 – Mouse Genome
Informatics), CCAAT-enhancer binding protein-beta (Cebpb), Elf5
and Gata3 have also been shown to play a role in lactogenic
differentiation (Kabotyanski et al., 2006; Kouros-Mehr et al., 2006;
Oakes et al., 2008; Seagroves et al., 2000). Thus, commitment to
cellular differentiation in the mammary gland appears to require
activation and coordination of multiple signaling pathways to insure
specific mammary lineage commitment is achieved.
Singleminded 2s (Sim2s) is a member of the bHLH/PAS family
of transcription factors and one of two orthologs of Drosophila sim.
In fruit flies, sim is considered a ‘master regulator’ of differentiation
that is both necessary and sufficient for proper midline cell
differentiation during central nervous system development (Chang
et al., 2001; Menne et al., 1997; Nambu et al., 1990). In mice, loss
of both Sim2s alleles leads to severe developmental abnormalities in
the diaphragm, ribs, cartilage and palate, suggesting that Sim2s
plays a role in the differentiation of many tissue types (Goshu et al.,
2002; Shamblott et al., 2002). We have recently shown that Sim2s
is expressed in human breast epithelial cells and is downregulated
in primary human breast cancer samples (Kwak et al., 2007).
Furthermore, reestablishment of Sim2s in highly invasive cancer
cells significantly inhibits growth and motility, suggesting that
Sim2s is a breast tumor suppressor (Kwak et al., 2007). In addition,
we found that SIM2s expression is suppressed by NOTCH and
CEBPb and that loss of SIM2s in normal human breast and mouse
mammary epithelium induces an invasive basal/stem cell-like
phenotype (Gustafson et al., 2009; Laffin et al., 2008). Sim2s-null
mouse mammary glands do not undergo proper ductal elongation or
luminal differentiation (Laffin et al., 2008). These data suggest that
Sim2s is required for establishing and/or maintaining differentiation
during normal mammary development. As loss of Sim2s results in
lethality shortly after birth, transplant studies were used to evaluate
the requirement of Sim2s for nulliparous mammary development.
This technique did not allow us to evaluate the role of Sim2s in
lactogenic differentiation; therefore, the objective of this study was
to further define the function of Sim2s in the developing mammary
epithelium using alternative models.
Mammary ductal epithelial cells are the primary targets of breast
cancer, and much effort has gone into determining the mechanisms
governing their development and function. Although it is evident
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SUMMARY
We have previously demonstrated that the bHLH/PAS transcription factor, singleminded 2s (Sim2s), is required for proper mammary
ductal morphogenesis and luminal epithelial differentiation. Furthermore, loss of Sim2s in breast cancer cells resulted in
downregulation of epithelial markers and acquisition of a basal-like phenotype. The objective of this study was to further define
the role of Sim2s in mammary differentiation. We found that Sim2s is developmentally regulated throughout mammary gland
development with highest expression during lactation. Mammary glands from nulliparous mice expressing Sim2s driven by the
mouse mammary tumor virus (MMTV) long terminal repeat (LTR) promoter were morphologically indistinguishable from wild-type
mice but displayed hallmarks of precocious lactogenic differentiation. These included elevated expression of the milk protein genes
Wap and Csn2, and apical localization of the lactation marker Npt2b. Consistent with the in vivo results, Sim2s enhanced prolactin-
mediated Csn2 expression in HC11 and CIT3 mouse mammary epithelial cells, and downregulation of Sim2s by shRNA in HC11 cells
inhibited Csn2 expression. Chromatin immunoprecipitation (ChIP) analyses of the Csn2 gene found that Sim2s associates with the
Csn2 promoter and re-ChIP experiments showed that Sim2s interacted with the RNA II polymerase (RNAPII) complex. Together,
these data demonstrate, for the first time, that Sim2s is required for establishing and maintaining mammary gland differentiation.
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that Sim2s is required for mammary ductal development, and that
loss of Sim2s promotes the acquisition of a basal phenotype, it
remains unclear what role Sim2s plays in promoting mammary
epithelial cell differentiation. Consistent with a role for Sim2s in
mammary epithelial differentiation, we report here that Sim2s is
developmentally regulated, showing maximal expression during
mid-lactation when the mammary gland undergoes terminal
differentiation. To further address the role of Sim2s in mammary
development, we have generated a transgenic mouse expressing
hemagglutinin (HA)-tagged Sim2s targeted to mammary epithelium
by the mouse mammary tumor virus (MMTV) long terminal repeat
(LTR) promoter. Analysis of MMTV-Sim2s transgenic females
revealed precocious lactogenic differentiation, and overexpression
of Sim2s in HC11 and CIT3 mouse mammary epithelial cells
markedly increased Csn2 expression following exposure to
lactogenic hormones. These studies describe, for the first time, a role
for Sim2s in regulating mammary differentiation in vitro and in vivo,
and might shed light on the nature of the relationship between Sim2s
and breast cancer progression.
MATERIALS AND METHODS
Chemicals
Ovine prolactin (Prl) was obtained from the National Hormone and Peptide
Program (NHPP), the National Institute of Diabetes and Digestive and
Kidney Diseases (NIDDK), and Dr Albert F. Parlow (Harbor-UCLA
Medical Center).
Animals
Nulliparous females were harvested during estrus as determined by vaginal
smears and, unless otherwise indicated, all females were primiparous. All
animals were housed three per cage under a standard 12-hour photoperiod.
The animals were provided with access to food and water ad libitum. All
procedures were approved by the University Laboratory Animal Care
Committee at Texas A&M University.
Cell culture
HC11 cells were grown in RPMI 1640 media (Gibco) supplemented with
10% calf serum (Atlanta Biologicals), 50 mg/ml gentamycin (Gibco),
5 mg/ml insulin (Sigma) and 10 ng/ml epidermal growth factor (EGF;
Sigma). To induce differentiation in HC11 cells, confluent plates were given
fresh media for 3 days followed by 24 hours of priming in RPMI 1640 media
supplemented with 10% charcoal-stripped horse serum, 50 mg/ml
gentamycin, 5 ug/ml insulin and 1 mg/ml hydrocortisone (Sigma). After
priming, fresh priming medium containing 1 mg/ml ovine Prl was added with
fresh media every 24 hours. CIT3 cells were grown in DMEM/F12
supplemented with 2% calf serum, 1% Pen-Strep (Gibco), 5 mg/ml insulin
and 5 ng/ml EGF. Confluent cells were treated with growth media lacking
EGF and containing 3 mg/ml hydrocortisone and 3 mg/ml ovine Prl.
RNA isolation and reverse transcription
RNA isolation and reverse transcription (RT) reactions were performed on
cultured cells as previously described (Metz et al., 2006). RNA was isolated
from tissue using Trizol reagent (Invitrogen), followed by purification using
a Qiagen RNEasy Mini Kit as described (Kwak et al., 2007).
In situ hybridization
In situ hybridization was performed as previously described (Wilkensen,
1993). Briefly, 35S-uridine triphosphate (Amersham Pharmacia Biotech,
Piscataway, NJ, USA)-labeled antisense and sense probes of mouse Sim2s
cDNA were made using the Riboprobe In Vitro Transcription Systems Kit
(Promega). The TOPO TA Cloning Kit (Invitrogen) was used to subclone a
437 bp RT-PCR product that was used generate sense and antisense probes
using the primers 5-AAATCAGCTAAACCCAAAAACACAAA-3 and
5-AGCATTCACAGGAGAAGGCTCAGAA-3. Mammary glands from
day 7 lactating mice were fixed in 4% paraformaldehyde, embedded in
paraffin and cut into 5 mm sections. After deparaffinization and rehydration,
sections were pretreated with 20 mg/ml proteinase K and 0.1 mM
triethanolamine/acetic anhydride before being coated with labeled probe and
incubated overnight at 55°C. Slides were washed with increasing stringency
using 5 SSC, followed by 50% formamide/2 SSC/100 mM b-
mercaptoethanol for 30 minutes each at 65°C. Slides were then treated with
20 mg/ml ribonuclease A for 30 minutes at 37°C, followed by final washes
of 2 SSC and 0.1 SSC for 15 minutes at 65°C, and dehydrated. To
visualize the 35S-uridine triphosphate label, slides were dipped in
photographic NTB-2 emulsion (Kodak, Rochester, NY, USA) and exposed
for 3 days. D-19 developer and fixer (Kodak) were used to develop the
slides, followed by hematoxylin counterstain.
PCR
RT-PCR and qRT-PCR were performed as described previously (Kwak et
al., 2007). Primers used for qRT-PCR reactions include: Sim2s, sense 5-
AACCAGCTCCCGTGTTTGAC-3 and antisense 5-ACTCTGA GG -
AACGGCGAAAA-3; Wap, sense 5-TCAGTCCATGTTCCCAAAAGC-
3 and antisense 5-CTCGTTGGTTTGGCAGATGA-3; Csn2, sense 5-
TGTGCTCCAGGCTAAAGTTCACT-3 and antisense 5-GGTTTGAGC -
CTGAGCATATGG-3; Lalba, sense 5-GAATGGGCCTG TGT TTT -
ATTTCA-3 and antisense 5-TGTGCTGCCGTTGTCGTT-3; Wdnm1,
sense 5-CGCCCCCACGCAGTT-3 and antisense 5-GCCA GAG -
CACGATGGATCTG-3; and Cldn7, sense 5-TCCCTGGTGTT -
GGGCTTCT-3 and antisense 5-ACAGCGTGTGCACTTCATG-3.
Primers used for RT-PCR reactions include: Sim2s transgene, sense 5-
AAGAACCAACCCATATCCCC-3 and antisense 5-GGCATAATGCG -
GCACATCATAAGG-3; Gapdh, sense 5-CTAACATCAAAT GGGGT -
GAGG-3 and antisense 5-TCATACTTGGCAGGTTTCTCC-3; and actin
exon, sense 5-TACAGCTTCACCACCACAGC-3 and antisense 5-
AAGGAAGGCTGGAAAAGAGC-3. The Csn2 promoter primer
sequence has been described elsewhere (Kabotyanski et al., 2006).
Generation of MMTV-Sim2s-HA mice
To generate transgenic mice, the Sim2s coding sequence containing a
hemagglutin (HA) tag on the 3 end was cloned into the MMTV-KCR
transgene cassette, pMKBPA (kindly provided by Dr Jeff Rosen, Baylor
College of Medicine, Houston, TX, USA). Mice (FVB background) were
generated in the Department of Molecular and Cellular Biology Transgenic
Mouse Core, Baylor College of Medicine, under the supervision of Dr
Francisco DeMayo. Two MMTV-Sim2s lines (3841 and 3829) were
generated that transmitted the transgene through the germline as detected by
PCR genotyping and immunohistochemistry for the HA epitope tag.
However, one line (3829) was found to also have Sim2s expression in tissues
outside of the mammary gland, including the hypothalamus and lung, and
therefore was not used for these studies. All procedures were approved and
followed the guidelines set forth by the Texas A&M Animal Use and Care
Committee.
Immunostaining
Immunohistochemical analyses were carried out as previously described
(Kwak et al., 2007). Following incubation in blocking solution, primary
antibodies were added overnight. Antibodies used included HA (Sigma),
Sim2s (Millipore), Npt2b (Alpha Diagnostics), b-casein (Santa Cruz),
aquaporin 5 (Alpha Diagnostics), P-Tyr Stat5a/b (Advantex Bioreagents)
and normal IgG (Upstate). Tissue processing and Hematoxylin and Eosin
(H&E) staining were performed by the Histology Core Facility in the Texas
A&M University College of Veterinary Medicine & Biomedical Sciences.
Wholemount analysis
Wholemount analysis was performed as previously described (Laffin et al.,
2008). To determine gross ductal branching, wholemount mammary glands
were imaged using a stereo microscope equipped with a digital camera and
analyzed using NIH Image software. Ductal penetration was defined as the
mean average of the length from the point of implantation to the ends of the
three longest ducts in each mammary gland. These three ducts were used to
calculate the number of branch points, or lateral ducts, per millimeter by
averaging the number of unbranched and ramified ducts. The number of
branch points directly contacting a vertical reference line, drawn through the
center of each mammary gland, were counted directly from pictures of
whole mounts.












Cells were washed in 10 ml PBS, collected in 2 ml PBS containing complete
protease inhibitor (CPI; Roche), pelleted and resuspended in lysis buffer (20
mM tris-Cl pH 8.0, 137 mM NaCl, 10% glycerol, 1% NP-40 and 2 mM
EDTA) containing CPI and phosphatase inhibitors (sodium orthovanadate,
sodium fluoride and sodium molybdate). Cell lysates were incubated with
rocking at 4°C for 30 minutes, centrifuged at 16,000 g for 10 minutes and
the supernatant was saved for western blot analysis. Protein concentration
was estimated using the RCDC Assay (BioRad). Samples were diluted in
water and 6 loading buffer, boiled for 5 minutes and subjected to SDS
PAGE. Proteins were transferred to PVDF membranes and blocked for 1
hour to overnight in PBS or TBS containing 0.5% Tween-20 and 5% non-
fat milk. Following incubation with primary and secondary antibodies,
membranes were developed using the Amersham ECL Plus Kit (Amersham
Pharmacia Biotech).
Retroviral transduction
Lentiviral transduction of HC11 and CIT3 cells was performed as previously
described (Kwak et al., 2007).
Chromatin immunoprecipitation assays
Crosslinking was achieved by the addition of 1% formaldehyde directly to
culture media for 10 minutes at room temperature with gentle agitation,
followed by the addition of glycine at 1.25 mM. Monolayers were washed
twice with ice-cold PBS and collected in 2 ml PBS plus CPI. Cell pellets
were resuspended in SDS lysis buffer containing CPI and incubated for 10
minutes on ice. Lysates were sonicated 1010 seconds, which resulted in
fragments of 200-1200 kb. Chromatin was diluted 5-fold in chromatin
immunoprecipitation (ChIP) dilution buffer containing CPI and pre-cleared
with 80 ml salmon sperm DNA/protein A/G agarose beads (Upstate) 230
minutes at 4°C with rocking. Antibodies were added overnight followed by
the addition of 60 ml beads for one hour. Beads were washed for 10 minutes
at 4°C with each of the following solutions: low salt buffer, high salt buffer,
LiCl buffer and twice in TE buffer (Tris, EDTA) at room temperature.
Complexes were eluted at room temperature in 10% SDS and 0.1 M sodium
bicarbonate. Crosslinks were reversed by addition of 0.3 M NaCl and 1 ml
10 mg/ml RNase A and incubated at 65°C for 5 hours. Two and a half
volumes of 100% EtOH were added and samples were placed at –20°C
overnight. Following centrifugation for 10 minutes at 16,000 g, pellets were
resuspended in 100 ml water containing tris-HCl pH 6.5, EDTA and 1 ml 20
mg/ml proteinase K. Samples were incubated at 45°C for 1.5 hours and
DNA was purified using Qiagen PCR Purification Kit (Qiagen). Two
microliters were used for subsequent PCR analysis. For re-ChIP
experiments, chromatin was incubated with antibody overnight at 4°C after
pre-clearing. Eighty microliters of protein A or protein G agarose beads were
added for 1 hour at 4°C and were washed according to standard ChIP
protocol. Following TE washes, beads were incubated with 1 volume of 20
mM dithiothreitol (DTT) for 30 minutes at 37°C with agitation. Supernatants
were collected and diluted to 1000 ml with re-ChIP Dilution Buffer
(Upstate). Ten percent of the eluate was reserved for input and the remaining
eluate was divided in half for no antibody control and immunoprecipitation
with a secondary antibody, respectively. After overnight incubation with the
antibody, immune complexes were precipitated with agarose beads and
washed/eluted according to standard ChIP protocol. Antibodies used in ChIP
analyses include AcH3 (Upstate), Sim2s (Millipore), RNAPII (Abcam),
Stat5 (Millipore) and normal IgG (Upstate).
RESULTS
Sim2s is differentially expressed during mammary
gland development
Based on our previous studies, we hypothesized that Sim2s plays a
role in establishing and/or maintaining mammary epithelial cell
phenotypes. Initially, we investigated Sim2s expression during
mouse mammary gland development by qRT-PCR. Total RNA
isolated from mouse mammary tissues at various developmental
time points was analyzed for the expression of the Sim2s isoform as
we have previously shown that mouse mammary epithelial cells do
not express full-length Sim2s (Laffin et al., 2008). Sim2s expression
is developmentally regulated. It is first detected in the mammary
glands of four-week-old pre-pubertal mice and then decreases in
mature virgin and early pregnant glands, which is consistent with
Sim2s playing a role in the differentiation of the luminal epithelial
cells as the TEBs progress through the gland (Laffin et al., 2008).
Sim2s expression increases during late pregnancy and throughout
lactation, peaking on day seven (L7) when the gland is fully
differentiated (Fig. 1A). In situ hybridization confirmed that Sim2s
mRNA increases during lactation in the luminal alveolar mammary
epithelial cells (Fig. 1B). Further, immunohistochemical analysis
revealed that the Sim2s protein is present in the nuclei of alveolar
epithelial cells in L7 mammary glands (Fig. 1C). To better define the
role of Sim2s during this process, additional samples obtained from
lactation days one and four were analyzed by qRT-PCR for Sim2s
and several milk protein markers of mammary differentiation. These
data show that Sim2s expression progressively increases during the
first week of lactation (Fig. 2A), coordinate with the milk protein
genes encoding whey acidic protein (Wap, Fig. 2B) and b-casein
(Csn2, Fig. 2C). Interestingly, two additional mammary
differentiation markers, a-lactalbumin (Lalba) and Wdnm1
(encoded by Expi), were expressed at high levels on lactation day 1
and remained relatively unchanged over the course of lactation (Fig.
2D,E).
The observation that Sim2s expression coincides with mammary
lactogenic differentiation led us to ask if Sim2s was sufficient to
regulate this process. As a first step, we generated transgenic mice
expressing an HA-tagged full-length Sim2s under control of the
MMTV LTR promoter (Fig. 3A). Two separate lines of MMTV-
Sim2s-HA mice were generated; however, PCR analyses revealed
that one of the lines displayed inappropriate transgene expression
with low mammary Sim2s-HA mRNA and high levels of transgene
message in the hypothalamus, spleen and lung (see Fig. S1 in the
supplementary material). In the second line, transgene expression
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Fig. 1. Sim2s expression is developmentally regulated in mouse
mammary tissues. (A) Total RNA isolated from C57 mouse mammary
glands (n=3 animals per group) at weeks 4 and 10 of virgin
development (V4 and V10), days 6 and 16 of pregnancy (P6 and P16),
days 1 and 7 of lactation (L1 and L7) and day 3 of involution (I3) was
used for qRT-PCR analysis of Sim2s expression. (B) In situ hybridization
analysis of Sim2s mRNA from 5-week-old virgin (top) and L7 (middle)
mouse mammary glands. The sense control is shown in the bottom
panel. Left images are Hematoxylin and Eosin (H&E)-stained adjacent
sections. (C) Immunohistochemical (ICH) staining of L7 FVB mouse
mammary glands for Sim2s (left panel) showing nuclear localization in













was detectable exclusively in mammary tissues (Fig. 3B); therefore,
further analyses were carried out using this line.
Immunohistochemical analysis of wild-type (WT) and MMTV-
Sim2s-HA mouse mammary sections using an HA antibody
demonstrated that the Sim2s transgene was specifically found in the
nucleus of mammary ductal epithelial cells (Fig. 3C; see also Fig.
S1 in the supplementary material). Morphologically, MMTV-Sim2s-
HA mammary glands were indistinguishable from WT glands
throughout development. During early virgin development, TEB
structures formed appropriately (Fig. 4A) and mature epithelial
ducts were seen throughout the mammary fat pad by 8 weeks of age
in transgenic females (Fig. 4B). During pregnancy, alveolar
structures expanded and the ability of alveolar epithelial cells to
undergo secretory differentiation was not impaired in glands from
MMTV-Sim2s-HA females (Fig. 4C,D). Mammary glands of
transgenic females were indistinguishable from WT glands during
lactation (Fig. 4E), and MMTV-Sim2s-HA females were able to
nurse large litters to weaning age. Following pup removal, the
mammary epithelium from MMTV-Sim2s-HA females fully
involuted and did not differ from that of WT females (Fig. 4E).
Transgenic MMTV-Sim2s nulliparous mice display
hallmarks of precocious lactogenic differentiation
The observation that Sim2s levels increase during lactation,
following the same pattern as a subset of milk proteins, led us to
hypothesize that Sim2s plays a role in gene regulation during
alveolar epithelial cell differentiation. Using qRT-PCR, we analyzed
mature virgin WT and MMTV-Sim2s-HA mouse mammary tissues
for Csn2, Wap, Lalba and Expi expression. Interestingly, both Csn2
and WapmRNA levels were significantly higher in eight-week-old
virgin transgenic mouse mammary tissues in comparison with WT
glands (Fig. 5A,B). However, expression of both Lalba (Fig. 5C)
and Expi (Fig. 5D) did not change as a result of Sim2s expression.
Although it has been reported that Csn2 expression changes during
the estrus cycle (Robinson et al., 1995), mice used in these studies
cycled normally (data not shown) and all of the nulliparous females
were sacrificed at estrus. Together, these data imply that Sim2s
enhances alveolar differentiation at the molecular level and might
play a role in regulating the expression of a subset of milk protein
genes. To further characterize the effects of Sim2s on mammary cell
differentiation, we analyzed sections of WT and MMTV-Sim2s-HA
mouse mammary glands for specific epithelial cell type cell markers.
aquaporin 5 (Aqp5) is an epithelial cell marker expressed on the
luminal surface of ductal mammary epithelial cells in non-pregnant
females (Shillingford et al., 2003). As mammary ductal epithelium
differentiates into alveolar cells, Aqp5 is lost and various luminal
surface solute transporters, such as Slc12a2 (Nkcc1) and Slc34a2
(Npt2b), are upregulated (Shillingford et al., 2003). Analysis of
eight-week-old virgin WT and transgenic females revealed no
differences in levels or localization of Aqp5 owing to Sim2s
expression (Fig. 5E, top). However, apical localization of Npt2b was
detected in approximately 70% of MMTV-Sim2s-HA glands (Fig.
5E, middle), suggesting that Sim2s expression is inducing a partial
alveolar phenotype in these cells. In support of this, and in
confirmation of the effects of Sim2s on Csn2 mRNA expression,
immunohistochemical analysis of WT and MMTV-Sim2s-HA
mammary sections revealed an increase in b-casein-positive
epithelial cells in virgin glands (Fig. 5E, bottom). Furthermore, we
found no differences in staining for phospho-Stat5a in WT and
Sim2s transgenics compared with glands from L7 mice (data not
shown), suggesting that this phenotype is not mediated by activation
of Stat5a. Together, these data indicate that Sim2s expression in
ductal epithelium induces a gene expression profile characteristic of
alveolar epithelial cells.
Sim2s is upregulated in prolactin-treated HC11
and CIT3 mouse mammary epithelial cells and is
required for Csn2 (b-casein) gene expression
To further analyze the molecular effects of Sim2s on mammary
epithelial cell differentiation, we moved to an in vitro model
system. The mouse mammary epithelial cell line HC11, derived
from the COMMA-D cell line that was isolated from a mid-
pregnant Balb/c mouse, has been widely used to study gene
expression during lactogenic differentiation in a relatively
homogeneous environment (Ball et al., 1988). Following
confluent growth arrest, HC11 cells can be treated with
hydrocortisone and prolactin (HC + PRL) to induce Csn2
expression. Sim2s expression was analyzed in undifferentiated
HC11 cells (UN) and in cells treated with HC + PRL for one or
four days (Fig. 6A). We found that Sim2s mRNA levels began to
increase within 24 hours after hormone stimulation and were
elevated further by day four, which is consistent with our in vivo
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Fig. 2. Sim2s expression patterns correlate with a subset of milk
protein genes during lactation. (A-E) Total RNA isolated from V8, L1,
L4 and L7 FVB mammary glands (n=5 animals per group) was used for
qRT-PCR analysis of (A) Sim2s, (B) Wap, (C) Csn2, (D) Lalba and (E) Expi
expression. Cldn7 was used to normalize all mammary qRT-PCR data.
Fig. 3. Generation of MMTV-Sim2s-HA transgenic mice.
(A) Schematic diagram of the MMTV-Sim2s-HA targeting construct. 
The MMTV-LTR construct was provided by Dr Jeffery Rosen at Baylor
College of Medicine. Exons 2 and 3 (E2, E3) and Intron 2 (I2) are
derived from the rabbit b-globin gene (RbG). The poly-A signal is
derived from the bovine growth hormone gene (bGHpA). (B) RT-PCR
analysis of pooled samples from three transgenic females showing
expression of the Sim2s-HA transgene exclusively in the mammary
gland. Hrt, heart; Hyp, hypothalamus; Kid, kidney; Lng, lung; Lvr, liver;
Neg, negative control (water); MG, mammary gland; Pit, pituitary; Ovr,
ovary; SG, salivary gland; Spl, spleen; Utr, uterus; WAT, white adipose
tissue. Gapdh was used as a loading control. (C) IHC analysis of HA












observations. Western blot analyses confirmed that both Sim2s
and b-casein levels increased in HC11 cells after four days of
hormone treatment (Fig. 6B). CIT3 cells, another COMMA-D-
derived line, were also found to upregulate Sim2s following
treatment with HC + PRL (Fig. 6C). These results indicate that
these cells represent an appropriate model to study Sim2s
regulation of mammary differentiation, and adequately
recapitulate the effect on Sim2s seen during lactogenic
differentiation in vivo.
A lentiviral transduction system was used to overexpress Sim2s in
both HC11 and CIT3 cells. Using qRT-PCR, we determined that Csn2
expression in cells expressing Sim2s, was significantly upregulated
following hormone stimulation in both HC11 and CIT3 cells (Fig.
7A,C, respectively). In HC11 cells, the increase in Csn2 was
detectable in as little as four hours after treatment with HC + PRL, and
continued through 24 hours (Fig. 7A). Western blot analyses
confirmed increased b-casein protein in Sim2s-overexpressing cells
(Fig. 7B), in agreement with the in vivo data. With the observation that
Sim2s enhances b-casein, we sought to determine whether Sim2s is
required for Csn2 expression in vitro. To do this, we transduced HC11
cells with an shRNA construct targeting exon 6 of the Sim2 gene.
Following selection, colonies were pooled and cells were treated for
4 days with HC + PRL and analyzed for Csn2 expression. Our results
show that Csn2 induction was reduced by approximately 50% in
HC11 cells targeted with the Sim2s shRNA construct (siSim2s) in
comparison with scrambled control cells (Fig. 7D). Western blot
analyses revealed that although Sim2s levels were not completely
abrogated in siSim2s cells, the reduction in protein was associated with
a decrease in b-Casein protein in this cell line (Fig. 7E). These data
suggest that Sim2s expression is necessary for the robust hormone-
mediated induction of Csn2 in this culture system.
Based on the data indicating a direct relationship between Sim2s
and Csn2 expression, and because Sim2s is a transcription factor, we
hypothesized that it is directly involved in regulating Csn2 gene
expression. Mechanisms governing Csn2 transcription have been
well documented, and within 1 hour of prolactin treatment,
increased association of Stat5a, GR, Cebpb and RNAPII can be
detected at the Csn2 proximal promoter (Kabotyanski et al., 2006).
Although this region of the Csn2 promoter does not contain
consensus Sim2s response elements, we monitored the occupancy
of proteins around the Csn2 transcription start site in control and
Sim2s-overexpressing HC11 cells (Fig. 8A, solid arrows).
Undifferentiated cells (UN) or cells treated for 4, 8 or 24 hours with
HC + PRL were analyzed for the presence of various transcription
factors using ChIP (Fig. 8B). In control cells, increased Stat5a
binding to the Csn2 promoter was observed 4 hours after HC + PRL
treatment and slowly decreased thereafter. In Sim2s cells, Stat5a
binding to the promoter region was also apparent 4 hours after HC
+ PRL treatment; however, the relative level of bound Stat5a was
much greater in Sim2s HC11 cells, peaking 8 hours after hormone
treatment and remaining high even at 24 hours post-induction (Fig.
8B). Sim2s binding to the Csn2 promoter was also detected within
4 hours in both control and Sim2s HC11 cells, the latter of which
maintained Sim2s occupancy even at 24 hours post-treatment. These
changes correlated with enhanced RNAPII association at the Csn2
promoter, and Sim2s cells showed both increased RNAPII binding
and duration of association in comparison with control HC11 cells
(Fig. 8B). Assessment of acetylated histone 3 (AcH3) binding,
indicative of active transcription, did not reveal significant
differences between control and Sim2s cells. To further examine the
association pattern of Sim2s and the RNAPII complex, we
performed re-ChIP analyses using chromatin from HC + PRL-
treated WT HC11 cells with a Sim2s antibody. Before crosslink
reversal, this chromatin was subjected to a second ChIP using an
RNAPII-specific antibody. The resulting chromatin was analyzed
for Csn2 promoter and exon 7 DNA by PCR (Fig. 8C). These results
show that Sim2s is associated with the RNAPII complex at the
promoter region of the Csn2 gene. The absence of Sim2s at the Actb
gene supports that this is gene-specific and not a general effect of
Sim2s on transcription (Fig. 8D). These results suggest that, rather
than altering the accessibility of Csn2 promoters in the population
of HC11 cells, Sim2s is enhancing recruitment of Stat5a and
RNAPII to the Csn2 promoter, which might result in higher levels
of mRNA transcription.
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Fig. 4. Assessment of mammary morphology in Sim2s-HA
transgenic and non-transgenic female mice. (A-F) Mammary glands
were isolated from (A) V5, (B) V8, (C) P6, (D) P16, (E) L2 and (F) I14 FVB
females, fixed in paraformaldehyde, sectioned and stained with H&E.
Scale bars: 100mm.
Fig. 5. Sim2s expression results in precocious expression of a
subset of milk proteins and alveolar epithelial cell surface
markers. (A-D) qRT-PCR was used to evaluate gene expression in
samples from nulliparous wild type (WT) and transgenic (Sim2s) females
(n=5 animals per group). (A) Csn2 expression. (B) Wap expression. 
(C) Lalba expression. (D) Expi expression. *, P<0.05. Cldn7 expression
was used to normalize qRT-PCR data. (E) Immunohistochemical analysis
of aquaporin 5 (Aqp5, top), the sodium-inorganic phosphate co-
transport protein Npt2b (middle) and b-casein (bottom) in mammary












This study demonstrates, for the first time, a role for Sim2s in
promoting differentiation of mammary alveolar epithelial cells. We
have previously shown that SIM2s is expressed in human breast
luminal epithelial cells and loss of SIM2s in normal human breast
cell lines and mouse mammary epithelium during virgin
development induces an invasive basal/stem cell-like phenotype
(Laffin et al., 2008; Gustafson et al., 2009). To further evaluate the
role of Sim2s in mammary gland development, we provide new data
demonstrating that Sim2s is upregulated in a stepwise manner during
early lactation, similar to that of Csn2 and Wap, but not Lalba and
Expi. Furthermore, overexpression of Sim2s in the mouse mammary
epithelium leads to an increase of a subset of differentiation markers.
In nulliparous transgenic female mice, mRNA levels of Csn2 and
Wap, but not Expi and Lalba, were significantly increased, revealing
slight differences in the mechanisms governing regulation of these
genes. Similarly, Sim2s expression increased in HC11 and CIT3
mouse mammary epithelial cells with lactogenic hormone treatment,
and overexpressing Sim2s in vitro resulted in enhanced Csn2
expression and association of Stat5a and RNAPII with the Csn2
promoter. These results suggest that Sim2s is required to establish
and maintain mammary ductal epithelial character in the developing
virgin gland and promote lactation-dependent gene expression.
The observation that Sim2s expression peaks after parturition points
toward Sim2s playing a role in the acquisition and maintenance of
alveolar differentiation. Analysis of milk protein gene expression in
whole tissue lysates from mammary glands of nulliparous transgenic
and WT females showed that only Csn2 and Wap were significantly
upregulated as a result of Sim2s overexpression. Taken with the data
showing differential patterns of milk protein gene expression during
the first week of lactation, these results suggest that distinct
mechanisms govern the regulation of genes in the mammary alveolar
epithelium, and that Sim2s might participate in regulating a subset of
lactation specific genes. This is consistent with previous studies that
looked at milk protein gene expression in mammary glands from
nulliparous mice and during pregnancy and lactation (Robinson et al.,
1995). The authors showed that, during pregnancy, Csn2 and Wap
were detectable at different times, but in the same cell type. The
expression of Lalba and Expi were temporally regulated during
pregnancy as well, but were not expressed in the same cells as Csn2
and Wap. During lactation, all four milk protein genes were highly
expressed, but expression levels were different between cells
contained within an alveolar structure. Recently, it was reported that
Wap expression in vivo is regulated by the demand of the nursing
offspring (Creamer et al., 2009). Using a Wap-luciferase reporter
transgenic mouse model, the results show that females nursing litters
of three pups produced less Wap than those nursing eight pups. The
increase in Sim2s expression during the first week of lactation might
reflect a role in modulating milk protein gene transcription in response
to increasing pup demand. The ChIP data obtained from HC11 cells
showing enhanced recruitment of RNAPII to the Csn2 promoter as a
result of Sim2s overexpression supports this theory. Based on these
studies, it is probable that specific factors expressed in the mammary
epithelium are responsible for the variability in milk protein gene
expression and for the coordinated regulation of Csn2 and Wap in the
same cells.
Using HC11 and CIT3 mouse mammary epithelial cell lines,
we determined that Sim2s expression increases after stimulation
with lactogenic hormones. In HC11 cells, we observed a
progressive increase in Sim2s expression over the course of 4 days
of hormone treatment, similar to the stepwise increase seen in
vivo. When Sim2s was overexpressed in these cell lines, Csn2
expression was significantly higher after hormone treatment, and
reduction of Sim2s in HC11 cells revealed a necessity of Sim2s
expression for robust Csn2 induction. ChIP analyses in HC11
cells demonstrated increased recruitment of RNAPII and Stat5a
to the Csn2 promoter in cells overexpressing Sim2s. In addition,
Sim2s itself was detected in association with the Csn2 promoter.
Significantly, the changes in RNAPII and Stat5a levels were seen
without an increase in AcH3 protein in association with the same
region. Re-ChIP analysis of both Sim2s and RNAPII showed that
both proteins associated with one another in a complex at the
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Fig. 6. Sim2s expression is upregulated in differentiated HC11
and CIT3 cells. (A) qRT-PCR was used to detect Sim2s in
undifferentiated HC11 cells (UN) and cells treated with HC + Prl for 1 or
4 days (PRL1 and PRL4). (B) Western blot analysis of Sim2s and b-casein
protein levels in undifferentiated (UN) HC11 cells and PRL4 cells. 
(C) Western blot analysis of Sim2s levels in UN CIT3 cells and PRL3 
cells. b-actin was used as a loading control for western analyses. Fig. 7. Sim2s is necessary and sufficient for robust prolactin-
mediated Csn2 expression. (A) qRT-PCR analysis of Csn2 expression
in control and Sim2s-overexpressing HC11 cells. Total RNA was isolated
from UN cells or cells treated for 4, 8 or 24 hours with HC + Prl. Csn2
expression in control cells is shown on a smaller scale in the inset panel.
(B) Western blot analysis of b-casein production in UN and HC + Prl
treated control and Sim2s-overexpressing HC11 cells. (C) qRT-PCR
analysis of Csn2 expression in control and Sim2s-overexpressing CIT3
cells. Total RNA was isolated from UN cells or PRL3 cells. (D) qRT-PCR
analysis of Csn2 expression in HC11 cells stably expressing a scrambled
shRNA sequence (control) or expressing shRNA targeting Sim2s
(siSim2s). (E) Western blot analysis of Sim2s and b-casein in control and











Csn2 promoter. These data indicate that overexpression of Sim2s
is not simply facilitating the recruitment of transcription factors
to more Csn2 promoters in the population of cells, but rather
enhancing the association of these proteins with a particular
promoter. However, the mechanism by which Sim2s
accomplishes this is unclear, although it might participate in
recruiting transcriptional activators, facilitating promoter escape
and/or elongation of RNAPII or acting as a transcriptional co-
activator through an undefined mechanism.
Although the RNAPII complex is large, and made up of many
subunits, it is possible that Sim2s associates with the holoenzyme to
target the complex to a particular class of genes during
differentiation. The conformation and subunit composition of the
general transcription factors can vary depending on the tissue, the
cell type within a tissue or the developmental stage of the tissue. In
Drosophila spermatocyte development, it has been proposed that
transcriptional complexes can vary in the composition of TBP-
associated factors (TAFs) that, together with TBP, form TFIID to
regulate the expression of testis-specific genes (Hiller et al., 2004).
TFIID associates with promoters of genes to recruit RNAPII and
promote transcription initiation. In mice, it has been shown that the
cellular localization of a TAF is another level of transcriptional
regulation during differentiation (Pointud et al., 2003). TAF7L was
identified as a germ cell-specific paralog of TAF7. In
spermatogonia, TAF7L is localized to the cytoplasm but becomes
nuclear and replaces TAF7 in the TFIID complex during
spermatogenesis. A study performed in mouse ovaries determined
that loss of TAF105 affected expression of a subset of genes
associated with follicle development (Freiman et al., 2001). The
authors proposed that cell type-specific subunits of TFIID in
mammalian cells lead to specific regulation of gene expression
programs during differentiation. Cell type-specific replacements for
TBP have been identified in spermatocytes and developing
myotubules as well (Deato and Tjian, 2007; Zhang et al., 2001). The
participation of Sim2s in recruiting RNAPII to specific gene
promoters could explain its association with the Csn2 regulatory
region in the absence of consensus Sim2s response elements.
In addition to changes in gene expression, mammary epithelial
cells from MMTV-Sim2s-HA mice also showed apical localization
of Npt2b. The sodium-inorganic phosphate transport protein is
normally detected during late pregnancy and lactation and is
localized to the luminal surface of alveolar epithelial cells,
suggesting that Sim2s promotes a change in cell fate. These results
are similar to the transcription factors, Elf5 and Gata3, which have
also been shown to play a role in mammary lactogenic
differentiation (Choi et al., 2009; Kouros-Mehr et al., 2006; Oakes
et al., 2008). Loss of Elf5 in the mammary epithelium led to
impaired alveolar formation and Stat5a activation (Choi et al.,
2009). In addition, the authors showed that Elf5 was associated with
the Csn2 promoter. Our data indicate that Sim2s associates with the
Csn2 promoter in vitro and contributes to enhanced transcription of
the Csn2 gene. In cultured epithelial cells, Elf5 reduction resulted in
a decrease in Stat5a, phosphorylated Stat5a and subsequently, b-
casein (Choi et al., 2009). Similarly, shRNA-mediated reduction of
Sim2s levels in HC11 cells attenuated Csn2 mRNA and protein
levels. Our studies did not investigate the requirement of Sim2s for
alveolar expansion during pregnancy; however, overexpression of
Sim2s in nulliparous females did not result in precocious
morphological changes seen prior to lactation. Gata3 has been
demonstrated to play a role in the maintenance of luminal cell fate
in vivo (Kouros-Mehr et al., 2006). Loss of Gata3 impaired ductal
outgrowth, alveolar formation and milk protein production. Our
previous studies with Sim2s-null transplanted mammary epithelium
suggest that Sim2s is also required for proper ductal outgrowth and
luminal epithelial differentiation during early virgin development,
which is taking place while the TEBs progress through the fat pad
(Laffin et al., 2008). In the studies herein, we have demonstrated a
requirement of Sim2s for robust prolactin-mediated Csn2
expression. Thus, it is possible that Sim2s activation lies either
downstream of Gata3 and Elf5 or plays a role in a parallel pathway
by not only maintaining ductal epithelial cell character, but also by
promoting alveolar differentiation.
A better understanding of how Sim2s governs mammary gland
development and the consequences of this regulation might
contribute significantly to cancer therapies aimed at inducing tumor
cell differentiation. With increasing evidence that breast cancer
progression correlates with decreased differentiation and induction
of an invasive basal/stem cell-like phenotype (Contesso et al., 1987;
Kouros-Mehr et al., 2008; Liu et al., 2007), deciphering signals
controlling normal mammary gland development and differentiation
will provide much needed insight into treating this disease. As we
have shown that loss of Sim2s leads to a basal/stem cell-like
phenotype and overexpression promotes differentiation (Laffin et
al., 2008; Gustafson et al., 2009), we hypothesize that re-establishing
SIM2s expression in highly aggressive human breast cancers will
promote tumor cell differentiation and block breast cancer
progression and metastasis.
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Fig. 8. Sim2s alters the binding of regulatory factors to the Csn2
promoter region. (A) Schematic diagram of the Csn2 gene. White
boxes represent non-coding exons and black boxes represent coding
exons (II-VIII). Arrows indicate the location of proximal promoter
primers. (B) ChIP analyses of the proximal promoter were performed on
chromatin isolated from UN HC11 cells or cells treated for 4, 8 or 24
hours with HC + Prl using the antibodies indicated to the left. (C) Re-
ChIP analysis of Sim2s and RNAPII at the proximal promoter of Csn2 in
control cells at PRL4. Following an initial pull down with Sim2s
antibody, chromatin was re-immunoprecipitated with RNAPII antibody
and the Csn2 promoter sequence was amplified using PCR. (D) ChIP
analysis of Sim2s and AcH3 occupancy of Actnb coding region in
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